Skip to main content
Premium Trial:

Request an Annual Quote

New York State OKs CBLPath's PCR-based Testing Services

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CBLPath today announced the New York State Department of Health has approved it to offer PCR-based testing of T-cells and B-cells.

Based in Rye Brook, NY, CBLPath provides sub-specialized anatomic pathology and molecular diagnostic laboratory services.

In a statement, David Bryant, CEO of the company, said that the industry is undergoing a convergence of anatomic, molecular, and digital pathology, combined with radiology. "With our added molecular capabilities, CBLPath is able to harness the full power of the convergence to provide better care to patients," he said.

CBLPath will expand its menu of molecular diagnostic tests during the next several months, the company said, without elaborating.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.